E for L Aim PCL

E for L Aim PCL has a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing, and a current ratio of 1.45, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -13.73 million THB, and its operating cash flow is only 34.40 million THB, which may limit its ability to fund operations and growth without external financing. The company's profitability is weak, with a return on equity of -4.44% and a return on assets of -1.71%, both significantly below the industry median for advanced medical equipment and technology firms. These metrics suggest the company is not generating returns that meet the cost of capital or industry benchmarks. E for L Aim PCL's revenue is concentrated in a single economic region, with no disclosed segment or geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in the healthcare equipment sector. The company's revenue growth is not disclosed in the latest financials, but its operating income and net income are negative, indicating a contraction in profitability. The capital expenditure of -4.38 million THB suggests some investment in growth, but the negative net income and free cash flow indicate that this investment is not yet generating returns. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could necessitate additional financing in the near term. However, the dilution risk is low, and no significant dilution sources are identified in the latest filings or transcripts. No recent events, such as filings or transcripts, are disclosed in the available data to provide additional context on the company's strategic direction or operational performance.